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Background/purpose: Few data have been published concerning tissue and systemic 
responses to resinous dental materials. The aim of this study was to compare and 
evaluate the biocompatibility of four kinds of dental self-etching/priming adhe-
sives by measuring tissue responses, local and systemic tumor necrosis factor (TNF) 
α expression, and oxidative stress parameters.
Materials and methods: Eighty rats were equally divided into 10 groups. Four dental 
adhesives (Clearfil SE Bond, iBond, Clearfil Protect Bond, and Adper Prompt L-Pop) 
were applied to connective tissue of the rats. In the control group, rats were operated 
on with no material being applied. Biocompatibilities of the bonding agents were 
evaluated according to tissue responses, histopathologic and biochemical TNF-α 
expressions, and levels of malondialdehyde, glutathione, superoxide dismutase and 
glutathione peroxidase activities 1 week and 1 month after initiation of treatment.
Results: All neutrophil levels and edema formation between the iBond group and 
the other groups were statistically significant after 1 week. Fibroblast levels in the 
Clearfil SE Bond group were higher than all other groups. Vascularization levels 
statistically differed between the Clearfil SE Bond and iBond groups, and between the 
Adper Prompt L-Pop and control groups. Tissue TNF-α levels statistically differed in 
all groups other than the control group. At the end of 1 month, the neutrophil level 
in the iBond group was higher than that in the control group. The differences in 
fibroblast levels after 1 month were statistically significant between the Clearfil SE 
Bond and Clearfil Protect Bond groups, and between the control and iBond groups. 
Tissue TNF-α levels were higher in the iBond, Clearfil Protect Bond, and Adper Prompt 
L-Pop groups than in the Clearfil SE Bond and control groups.
Conclusion: There were no statistical differences in levels of serum TNF-α and oxida-
tive stress parameters in any groups during the course of the study. The four differ-
ent adhesive systems exhibited different degrees of local toxicity to the subsurface 
of the skin of rats, but no systemic toxicity was detected.
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Introduction
The increasing use of esthetic restorations has led 
to extensive use of dental adhesives. Today, many 
commercial brands of bonding agents are available 
for clinical use. The latest generation of dentin-
bonding agents seems to be simpler to use and 
more efficient than earlier generations.1 However, 
the use of new materials with new chemical prop-
erties has raised questions concerning the biologic 
effects of the materials and techniques. Addition-
ally, the reported biologic effects of dentin-bonding 
agents range from none to severe, depending on 
several factors.2
To evaluate the biocompatibility of dental mate-
rials, a sequence of tests must be performed, includ-
ing in vitro assays for mutagenesis and cytotoxicity 
(initial tests), local toxicity reactions by intraosseous 
or subcutaneous implantation of the material in small 
laboratory animals (secondary tests), and finally 
usage tests.3
The immune system triggers inflammatory reac-
tions to limit tissue damage against invading or for-
eign molecules.4 The inflammatory response occurs 
in vascularized connective tissue, including plasma, 
circulating cells, blood vessels, and cellular and ex-
tracellular constituents of connective tissue, such 
as mast cells, fibroblasts and lymphocytes.5
Cytokines are proteins produced by many types 
of cells that modulate the function of other cell 
types. Long known to be involved in cellular immune 
responses, these products have additional effects 
that play important roles in both acute and chronic 
inflammation.5 The major cytokines that mediate 
inflammation are interleukin 1 and tumor necrosis 
factor (TNF). There are two types of TNF: TNF-α 
and TNF-β.6
In the biologic evaluation of adhesive systems, 
one interesting possibility would be to detect the 
production of intracellular reactive oxidative species 
(ROS) induced by leachable monomers.7 Oxidative 
stress (OS) is a general term used to describe the 
steady-state level of oxidative damage in a cell, 
tissue or organ caused by ROS. This damage can af-
fect a specific molecule or the entire organism. 
ROS, such as free radicals and peroxides, repre-
sent a class of molecules derived from the metab-
olism of oxygen and inherently exist in all aerobic 
organisms.8,9 Oxygen-centered free radicals are 
known as oxygen free radicals (OFRs).10 Examples 
of OFRs are the superoxide anion (O2•−), hydroxyl 
(OH•−), peroxyl (RO2•−), alkoxyl (RO•−), and hydro-
peroxyl (HO2•−) radicals.11 These play different roles 
in vivo. However, OFRs may be very damaging, be-
cause they can oxidize lipids in cell membranes, 
enzymes, proteins in tissues, carbohydrates, and 
DNA.9,10
To prevent damage caused by OFRs, multiple 
defense systems, collectively called antioxidants, 
are present in serum, erythrocytes, and other or-
gans and tissues. The antioxidant system consists 
of antioxidant molecules such as glutathione (GSH), 
vitamins A, E and C, ceruloplasmin, transferrin, albu-
min, and various antioxidant enzymes. Erythrocytes 
are excellently equipped to handle intracellular OS 
through the combined activity of glutathione per-
oxidase (GPX), and superoxide dismutase (SOD). SOD 
is believed to play a major role in the first line of 
antioxidant defense.12
Lipid peroxidation is the oxidative conversion of 
polyunsaturated fatty acid products such as malond-
ialdehyde (MDA), which is usually measured as total 
thiobarbituric acid-reactive substances (TBARSs), 
or lipid peroxides. This is the most studied and bi-
ologically relevant free radical reaction.13,14
It was reported that hypertonic acidic agents 
applied to dentin following cavity preparation re-
move the smear layer and smear plugs as well as 
decalcify the peritubular dentin.15 The outward 
dentin fluid movement then interferes with the 
penetration and setting of the bonding agent, from 
which uncured residual components that diffuse 
through the dentin are released during the light-
curing procedure. Therefore, it is important to 
employ biocompatible dental materials near pulp 
tissues. However, few data have been published 
concerning tissue responses to self-etching/priming 
dental adhesives.16
Several in vivo studies have reported that both 
dental materials and their components as well as 
microleakage play influential roles in the inflam-
matory tissue response.17,18 The aim of this study 
was to investigate tissue reactions of dentin bond-
ing agents without the effect of microleakage or 
bacterial contamination.
The null hypotheses to be tested were: (1) there 
is no difference in the tissue reaction ability and 
local/systemic TNF-α production among the four 
commercially available self-etching/priming dentin-
bonding agents; and (2) that all bonding agents will 
cause OS in rats.
Materials and methods
The study was conducted at the Ataturk University 
Experimental Animal and Research Center. The 
Ataturk University Ethics and Research Committee 
on the Care, Welfare and Use of Laboratory Animals 
approved the experimental protocol. Eighty male 
Sprague-Dawley rats, 80−100 days old and weighing 
140−268 g, were used.
The rats were divided into 10 groups with eight 
rats in each, placed in cages (60 × 60 × 45 cm), and 
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with permitted ad libitum consumption of a con-
ventional diet formulated to meet nutrient require-
ments assessed by the National Research Council.19 
Fresh water was also available ad libitum during 
the experiment. Rat adaptation was observed for 
1 week before the experiment began.
The bonding agents used were Clearfil SE Bond 
(Kuraray America, Inc., New York, NY, USA), iBond 
(Heraeus Kulzer GmbH, Hanau, Germany), Clearfil 
Protect Bond (Kuraray America, Inc.), and Adper 
Prompt L-Pop (3M Dental Products, St. Paul, MN, 
USA). Applications of these agents to the rats in 
the groups, the durations of treatment courses, 
and manufacturers are shown in Tables 1 and 2. 
Groups CI and CII were assigned for control purposes. 
Group CI represented a control group of 1-week 
findings and Group CII of 1-month findings. Rats in 
the control groups were operated on, but no mate-
rial was applied.
An induction mixture of ketamine hydrochloride 
(Ketalar, Eczacıbaşı, Lüleburgaz, Turkey) at 50 mg/
kg and xylazine hydrochloride (Rompun, Bayer, 
Istanbul, Turkey) at 5 mg/kg was administered in-
tramuscularly, followed by maintaining inhalation 
anesthesia using 1.5−4% sevoflurane (Sevorane; 
Abbott Laboratories, Istanbul, Turkey) volatilized 
with oxygen and delivered by means of a snout 
mask.
Table 1. Applied materials, experimental times, and groups
Group Applied materials Time Weight (g)
Group SEI Clearfil SE Bond 1 wk 190−226
Group iBI iBond 1 wk 210−240
Group PBI Clearfil Protect Bond 1 wk 176−242
Group PLPI Adper Prompt L-Pop 1 wk 190−206
Group CI Control 1 wk 166−268
Group SEII Clearfil SE Bond  1 mo 144−190
Group iBII iBond 1 mo 206−246
Group PBII Clearfil Protect Bond 1 mo 174−234
Group PLPII Adper Prompt L-Pop 1 mo 168−220
Group CII Control 1 mo 140−208
Table 2. Components and manufacturers of the bonding agents
Classification Product Manufacturer Components Batch no. pH
One-step  Adper 3M Dental Liquid A or compartment: 187444 < 1
 self-etching  Prompt   Products,  methacrylated phosphoric
  L-Pop  St. Paul,   acid esters, photoinitiator,
   MN, USA  stabilizers
   Liquid B or compartment: 
    water, HEMA, polyalkenoic 
    acid, stabilizers
One-step self- iBond Heraeus Kulzer UDMA, 4-META, acetone, 010067 2.0−2.2
 etching (no   GmbH, Hanau,   water, glutaraldehyde,
 mixing required)   Germany  camphorquinone
Two-step  Clearfil Kuraray America, Primer: MDP, HEMA, 389 1.9
 self-etching  SE Bond  Inc., New York,   dimethacrylates, water,
   NY, USA  photoinitiator
   Bond: MDP, Bis-GMA, 
    HEMA, photoinitiator, 
    colloidal silica
Two-step self- Clearfil Kuraray America, Primer: MDP, MDPB, HEMA,  Primer 5B 1.9
 etching (with   Protect  Inc., New York,  water  Adeziv 10B
 an antibacterial   Bond  NY, USA Bond: MDP, Bis-GMA,
 feature)    HEMA, camphorquinone, 
    colloidal silica, NaF
HEMA = hydroxyethyl methacrylate; UDMA = urethane dimethacrylate; 4-META = 4-methacryloxyethyltrimellitic acid anhydride; 
MDP = 10-methacryloyloxydecyl dihydrogen phosphate; Bis-GMA = bisphenol A diglycidyl methacrylate.
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Under general anesthesia, the dorsal side was 
shaved and the material applied using a 10% povi-
done iodine antiseptic solution (Poviiodeks; Kim-Pa 
Co., Istanbul, Turkey), and a sterile drape was placed 
over the side with the animal in the lateral recum-
bent position. An incision was made using a 1-cm 
scalpel (no. 11) inserted unilaterally under the skin. 
A gap was prepared by inserting a retractor into 
the incision region to provide an application zone 
for the bonding agents away from the incision side. 
The implantation area for the applied material was 
then separated from the area of wound inflamma-
tion. Dental bonding systems (DBSs) were applied 
in accordance with the manufacturers’ instructions 
onto subcutaneous connective tissue (Table 3). 
The wound was then closed and the skin sutured 
using 4.0 sterile sutures (Maxon 4.0, lot R77386G; 
Cyanamid of Great Britain, Gosport, Hampshire, 
UK). In the control groups, the same operation was 
performed but no material was applied. The ani-
mals were free to move about.
At the end of the procedure, blood from all of 
the rats was drawn into vacutainer tubes from the 
heart under the same anesthetic procedure as de-
scribed above, allowed to clot, and then centrifuged 
at 3500g (5 minutes, 4ºC). The serum was immedi-
ately frozen in 1-mL aliquots and stored at −80ºC 
until the biochemical analyses were performed. 
One subject from the PLPI group died at the time 
of anesthesia. Specimens were thawed immedi-
ately before the assay, and hemolyzed specimens 
were excluded. Serum TNF-α was measured using 
a commercial enzyme-linked immunosorbent assay 
kit according to the manufacturer’s instructions 
(series no. 11828014; Bender MedSystems, Vienna, 
Austria).
The subjects were sacrificed using the surgical 
exsanguination technique. The operative zone was 
extracted together with the connective tissue and 
fixed with 10% neutralized buffered formalin. Speci-
mens were then embedded in paraffin, and serial 
sections 5 μm thick were cut on a microtome and 
stained with hematoxylin and eosin. All sections 
were blindly evaluated by two examiners for five 
histologic features: neutrophils, fibroblasts, lympho-
cytes, vascularization, and edema formation. The 
state of the various types of inflammatory cells, 
their occurrence, and tissue responses were graded 
from 0 to 3 as described in Table 4.
Local production of TNF-α was evaluated immu-
nohistochemically using an anti-TNF-α kit (series 
no. 10026.05; DakoCytomation, Glostrup, Denmark) 
according to the manufacturer’s protocol. Briefly, 
tissue samples on polylysine-coated slides were 
deparaffinized and rehydrated. Microwave antigen 
retrieval was then performed, and samples were 
incubated in a 3% H2O2 solution to inhibit endog-
enous peroxidase. To block nonspecific background 
staining, sections were incubated with a blocking 
solution. Sections were then incubated with a pri-
mary anti-TNF-α antibody, followed by incubation 
with a biotinylated goat anti-mouse antibody. After 
Table 3. Application techniques of the dental bonding systems
Product Application procedure
Adper Prompt L-Pop 1. Press compartment 1.
 2. Fold the red chamber onto the yellow chamber.
 3a. Press on the chambers.
 3b. Spin or churn applicator to mix adhesive.
 4. Apply 0.1 mL of adhesive to the connective tissue.
 5. Wait 15 s.
 6. Gently but thoroughly air-dry to remove the aqueous solvent.
 7. Light-cure for 10 s.
iBond 1. Shake vigorously.
 2. Apply 0.1 mL of adhesive to the connective tissue.
 3. Wait 20 s.
 4. Gently but thoroughly air-dry to remove the aqueous solvent.
 5. Light-cure for 10 s.
Clearfil SE Bond 1. Apply 0.05 mL of primer to the connective tissue and let sit for 20 s.
 2. Dry with mild air flow.
 3. Apply 0.05 mL (total 0.1 mL) of bonding agent and distribute with gentle air flow.
 4. Light-cure for 10 s.
Clearfil Protect Bond 1. Apply 0.05 mL of primer to the connective tissue and let sit for 20 s.
 2. Dry gently with mild air flow.
 3. Apply 0.05 mL (total 0.1 mL) of bonding agent and distribute with gentle air flow.
 4. Light-cure for 10 s.
140 Y.O. Zorba et al
incubation with the chromogenic substrate (DAB), 
sections were counterstained with hematoxylin 
and eosin.
The intensities of local TNF-α levels and tissue re-
actions were evaluated using a light microscope 
(100× and 200× magnification; Olympus BX51; 
Olympus Europa Holding, Hamburg, Germany). All 
analyses were performed by two pathologists who 
were blinded to the group assignments. The evalua-
tion of staining of cytoplasmic TNF-α in the tissue was 
scored as a percentage of results, and the tissue re-
actions were classified as mild, moderate or severe.
To measure OS, 1 mL of blood was taken from the 
heart using a 24-gauge angiocatheter (Hayat Medical 
Instruments Co., Istanbul, Turkey) 1 week and 1 
month after implantation. Erythrocyte sediments 
were prepared for the analyses. Erythrocytes were 
then hemolyzed by diluting with deionized water 
(50-fold), and the analyses were carried out in 
these hemolyzed supernatant fractions. Hemoglobin 
(Hb) values of samples were measured using a Gen-S 
counter hematology analyzer (Beckman Coulter, Inc., 
Fullerton, CA, USA). Hemolysate samples were kept 
at −80ºC until biochemical determination.
The MDA measurement, an important indicator 
of OS, was based on the spectrophotometric absorb-
ance of the pink-colored product of the thiobarbi-
turic acid-reactive substance (TBARS) complex.20 
Total TBARSs were expressed as MDA. Results are 
expressed as nanomole per gram of Hb. SOD activity 
was measured by nitroblue tetrazolium reduction 
by O2•− generated by the xanthine/xanthine oxidase 
system.21 SOD activity was measured at 560 nm by 
detecting the inhibition of this reaction, and was 
expressed as unit per milligram of Hb. GPX activity 
was detected according to the method described by 
Paglia and Valentine.22 By measuring the absorbance 
change in NADPH at 340 nm per minute and using the 
molar extinction coefficient of NADPH, GPX activ-
ity was calculated as unit per gram of Hb. The total 
GSH level was measured spectrophotometrically 
at 412 nm using a glutathione disulfide reductase 
recycling method, as described by Tietze.23 In this 
method, the rate of yellow-colored 5-thio-2-
nitrobenzoic acid production is directly proportional 
to the concentration of GSH in the sample. Results 
were expressed as micromole per gram of Hb.
Statistical analyses were carried out using analysis 
of variance among MDA, GSH, SOD, and GPX levels, 
and serum and tissue TNF-α levels. Differences be-
tween groups were evaluated using Duncan’s multi-
ple comparison test at a significance level of P < 0.05.
For the statistical analysis of the tissue reaction, 
Mann-Whitney U and Kruskal-Wallis tests were per-
formed to determine whether there was a statisti-
cally significant difference (P < 0.05) among ranked 
groups and times.
Results
Gross findings
In the 1-week findings, Groups CI and SEI, with the 
exception of two subjects (for which exudate was 
observed after scab removal), showed healing in 
the wound. However, there was no evidence of 
healing in the operative zone, and a thick scab, 
Table 4. Inflammatory tissue response
 Score 0 Score 1 Score 2 Score 3
Neutrophils None or a few scattered Some neutrophils A moderate number Many neutrophils
 neutrophils present present in the of neutrophils present present in the
 in the operative area operative area in the operative area operative area
Fibroblasts None or a few scattered Some fibroblasts A moderate number Many fibroblasts
 fibroblasts present present in the of fibroblasts present present in the
 in the operative area operative area in the operative area operative area
Lymphocytes None or a few scattered Some lymphocytes A moderate number of Many lymphocytes
 lymphocytes present present in the lymphocytes present present in the
 in the operative area operative area in the operative area operative area
Vascularization None or slight scattered  Some vascularization Moderate Much vascularization
 vascularization present  present in the vascularization present in the
 in the operative area operative area present in the operative area
   operative area
Edema None or slight scattered  Some edema Moderate edema Severe edema
 edema formation present  formation present formation present formation present
 in the operative area in the operative in the operative area in the operative 
  area   area
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inflammation and exudate were present in all sub-
jects in the groups.
In the 1-month findings, the SEII, PBII and CII 
groups exhibited healed wounds, and no scabs were 
seen. However, no healing was observed in two sub-
jects in the iBII group and one in the PLPII group.
Histopathologic findings at 1 week
Fibroblast levels in Group SEI were higher than in 
the other groups (P < 0.01). Although neutrophil and 
vascularization levels were similar to those in the 
control group, edema formation and lymphocyte 
counts were slightly higher than in Group CI (control 
group, 1-week findings), although the difference 
was not statistically significant (Fig. 1).
Neutrophil, vascularization and edema levels 
were significantly higher in Group iBI compared 
with the other groups (P < 0.01), and fibroblast lev-
els were lower than those in the other groups 
(P < 0.01), except for the controls (Fig. 1).
Vascularization and edema formation were higher 
in the PBI group than in the SEI and CI groups. 
Neutrophil levels were higher in the PBI group than 
in all other groups (P < 0.01) except for Group iBI 
at 1 week (Fig. 1).
Neutrophil levels were higher in Group PLPI 
than in Groups SEI and CI (P < 0.01) but were lower 
PBI iBI
SEICI
PLPI
Fig. 1 Histopathologic appearance of the experimental 
and control groups at the end of the first week (Original 
magnification: Group SEI: ×200, Group iBI: ×200, Group 
PBI: ×100, Group PLPI: ×200, Group CI: 200×). The bond-
ing agents are indicated by the arrows.
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than in Group iBI. Lymphocyte and fibroblast levels 
were higher than in the other groups, except for 
Group SEI. However, these findings were not sta-
tistically significant. In addition, the vasculariza-
tion level was lower in Group PLPI than in Groups 
iBI and PBI and higher than in the controls and in 
Group SEI (P < 0.01) (Fig. 1).
Levels of lymphocyte and neutrophil infiltration 
were low in density in Group CI (control). Edema 
and fibroblast levels were determined to be small, 
except in two subjects. The neutrophil level in the 
control group differed from that in Groups iBI and 
PBI (P < 0.01). Fibroblast and vascularization levels 
differed from those in Group iBI (P < 0.01) (Fig. 1).
Histopathologic findings at 1 month
Fibroblast and lymphocyte counts were higher in 
Group SEII than in Group CII (1-month findings 
in the control group; P < 0.001 for fibroblasts and 
P < 0.01 for lymphocytes), but the other data were 
similar to the controls. When compared with the 
1-week findings, neutrophil and vascularization 
levels had decreased (P < 0.05) but the fibroblast 
level had increased (P < 0.05; Fig. 2).
Although neutrophil and lymphocyte levels 
were higher in Group iBII than in the other groups 
(P < 0.05), the fibroblast level was lower (P < 0.001). 
Compared with the 1-week findings, the fibroblast 
CII
CII
SEII
PBII
iBII
PLPII
Fig. 2 Microscopic appearance of the application region 
of the dental bonding agents and the control group after 
1 month (original magnification: Group SEII, ×200; Group 
iBII, ×200; Group PBII: ×100; Group PLPII, ×200; Group CII, 
×100). The bonding agents are indicated by the arrows.
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level had increased (P < 0.05) but edema, neutro-
phil (P < 0.05), and vascularization (P < 0.01) levels 
had decreased (Fig. 2).
All findings in Group PBII were higher than those 
in Group CII. When compared with the 1-week data, 
fibroblastic activity had risen (P < 0.05) but neu-
trophil (P < 0.05) and vascularization levels (P < 0.01) 
had decreased (Fig. 2).
All findings in Group PLPII were higher than in 
the controls. Lymphocyte activity differed from 
those in groups SEII and PBII. Compared with 1-
week data, fibroblastic activity had risen (P < 0.05) 
but the other findings had decreased (P < 0.05) 
(Fig. 2).
All inflammation values in Group CII (control) 
were lower than those in the other 1-month groups. 
The values were lower in degree, and all findings 
were statistically significant (P < 0.05), except for 
the vascularization level compared with group SEII 
(Fig. 2). The statistical analyses showed that the 
1-week and 1-month findings differed with respect 
to neutrophil (P < 0.05), fibroblast (P < 0.05) and 
vascularization levels (P < 0.01).
Tissue TNF-a
During the first week, the result for local TNF-α 
secretion in Group CI (control) was statistically 
lower than in the other groups. In Groups SEI 
and PBI, TNF-α levels were higher than in the con-
trols but lower than in Groups iBI and PLPI. The 
TNF-α receptor-binding level was concentrated in 
Groups iBI and PLPI. Differences between Groups 
SEI and PBI and between Groups iBI and PLPI were 
not significant, but those between the first-week 
groups and Group CI were significant (P < 0.001) 
(Fig. 3).
At the end of the first month, no differences 
were determined between Groups SEII and CII (con-
trol) in terms of TNF-α levels, but Groups iBII, PBII 
and PLPII statistically differed from Groups CII and 
SEII. Differences in Groups iBII, PBII and PLPII were 
statistically significant (P < 0.001; Fig. 4).
In addition, the TNF-α level in the control group 
decreased compared with the first-week level. In 
Groups iBII and PBII, TNF-α values were lower com-
pared with those in the first week, but were still 
higher than those in Groups SEII and PLPII (P < 0.001; 
Table 5).
Biochemical findings
There were no differences between the control and 
the other groups in terms of serum TNF-α and OFR 
production (MDA, GSH, SOD, and GPX) levels at 
either 1 week or 1 month. Results of the study are 
summarized in Tables 5−7.
Discussion
No studies have so far investigated the biocompat-
ibility of the systemic toxicity of DBSs via ROS pro-
duction. We determined no differences between 
the control and experimental groups in terms of 
MDA, GSH, SOD, and GPX values, important indica-
tors of OS.
The biocompatibility of dentin-bonding agents 
is imperative, since they are placed on etched 
dentin near the pulp, where tubular density and 
diameter are the greatest.24
With all materials used in restorative dentistry, 
there is some risk of biologic reactions because of 
incomplete polymerization. DBSs are usually poly-
merized by photoactivation, and free monomers may 
be released from resinous materials before and after 
polymerization. Theoretically, a 100% conversion of 
monomers to polymers is possible, but as much as 
25−50% of the methacrylate monomer double-bonds 
actually remain unreacted in the polymer.25 The 
unpolymerized monomer may be responsible for 
biologic reactions if it passes through the dentinal 
tubules and reaches the pulp tissue.26
The immune system triggers inflammatory reac-
tions to limit tissue damage from invading or for-
eign molecules.4 In considering compatibility and 
its relationship to other in vivo elements following 
implantation tests, appreciation of wound healing 
is essential.27 The first phase of healing is the acute 
inflammatory response, which includes exudation 
of fluid and plasma proteins (edema) and the emi-
gration of leukocytes, predominantly neutrophils. 
Following the acute inflammatory response, chronic 
inflammation and normal wound healing occur, with 
the presence of lymphocytes and macrophages, the 
proliferation of blood vessels, and fibroblasts.5 We 
used edema, and neutrophil and lymphocyte levels 
to assess the acute inflammatory tissue response 
and fibroblast and vascularization levels to assess 
wound healing levels. We found that when adhe-
sive systems were applied to connective tissue, 
they caused an inflammatory tissue response and 
delayed the wound healing time compared with 
the control groups, at both 1 week and 1 month.
Some researchers recently determined that no 
adverse effect occurs when adhesive systems are 
applied as pulp capping materials, in spite of the 
manufacturers’ instructions to the contrary.28 Con-
sequently, the biocompatibility and cytotoxicity of 
dental composites and their components have been 
analyzed, because these materials were initially 
recommended for application to dentin or, more 
recently, for direct pulp capping.29 Jontell et al.30 
emphasized that resin components may evoke an 
immune reaction by spleen cells. In our study, all 
DBSs exhibited inflammatory reactions to differing 
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degrees. Wound healing was delayed in all subjects 
compared with control groups at both 1 week and 
1 month. Reactions induced by DBSs can also en-
hance their acidity.31 We used four different self-
etching/priming DBSs with different acidities. Some 
researchers suggested that applying self-etching/
priming adhesive systems to contacted pulp of 
healthy dog teeth does not lead to acceptable re-
pair of the dentine-pulp complex.32 Additionally, 
de Souza Costa et al.33 determined that calcium 
hydroxide remains the pulp capping agent of choice 
for mechanically exposed human pulp. Self-etching 
adhesive systems do not allow complete connec-
tive tissue repair adjacent to the pulp exposure 
site. These findings are in agreement with those of 
the present study.
TNF-α is an inflammatory cytokine produced by 
macrophages/monocytes during acute inflamma-
tion, is responsible for a diverse range of signaling 
events within cells, and leads to necrosis or apop-
tosis. Proteins are also important for resistance to 
infection.6
We used local TNF-α levels to compare the bio-
logic reactions of the DBSs. The eight working 
groups exhibited differing degrees of tissue reac-
tions. Inflammation was maintained at different 
levels at 1 week and 1 month. In addition, wound 
healing was slow in all groups compared with the 
CI
SEI
PBI
PLPI
iBI
Fig. 3 Appearance of local tumor necrosis factor α secre-
tion in the experimental and control groups at 1 week 
(original magnification: Group SEI, ×200; Group iBI, ×100; 
Group PBI, ×100; Group PLPI, ×100; Group CI, ×100). 
Positively stained cells are brown or red on immunohisto-
chemical staining, according to the selected chromogen. 
In the present study, brown-stained cells indicate positive 
staining.
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Table 5. Tissue tumor necrosis factor (TNF) α level*
 
Control Clearfil SE Bond iBond
 Clearfil Adper Prompt
    Protect Bond L-Pop
TNF-α, mean (SD) (%)
 1 wk 23.125† 38.75‡ 78.7500§ 47.50‡ 76.42§ 
 (9.6130) (19.5941) (11.2599) (7.5592) (14.6385)
 1 mo 13.750 15.00 70.62¶ 25.00#  16.87# 
 (4.4320) (7.0710) (10.5008) (10.3509) (5.9386)
*Means with different symbols in a given row statistically differ (P < 0.05). SD = standard deviation.
CII SEII
PBII
iBII
PLPII
Fig. 4 Immunohistochemical appearance of the operative 
regions of the experimental and control groups at 1 month 
(original magnification: Group SEII, ×200; Group iBII, ×100; 
Group PBII, ×100; Group PLPII, ×200; Group CII: ×100).
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control groups in terms of histopathologic and bio-
chemical findings. Our results are in agreement 
with those of Cortes et al.34 who determined local-
ized abscess formation and no dentinal bridge for-
mation after applying different adhesives to rat 
molar tooth pulp. Rakich et al.35 also demonstrated 
that the application of dentin bonding agents to 
cell culture medium causes secretion of TNF-α from 
macrophages. However, other researchers reported 
that resin-based materials allow pulp healing and 
tertiary dentine deposition.28
In this study, tissue levels of TNF-α were com-
pared to evaluate systemic biologic reactions to the 
various dentin bonding agents. No systemic toxic-
ity derived from the dentin bonding agents was de-
termined. The findings of this study are compatible 
Table 6. Neutrophil, fibroblast, vascularization, and edema scores at 1 week and 1 month
 
Control Clearfil SE Bond iBond
 Clearfil  Adper Prompt
    Protect Bond L-Pop
Neutrophil score (%)
 1 wk
  1 87.5 62.5 − 12.5 42.9
  2 12.5 25.0 37.5 62.5 42.9
  3 − 12.5 62.5 25.0 14.2
 1 mo     
  1 87.5 75.0 25.0 75.0 50.0
  2 12.5 25.0 50.0 25.0 50.0
  3 − − 25.0 − −
Fibroblast score (%)     
 1 wk     
  1 87.5 12.5 75.0 50.0 42.9
  2 12.5 25.0 25.0 50.0 42.9
  3 − 62.5 − − 14.2
 1 mo     
  1 87.5 − 50.0 37.5 87.5
  2 12.5 37.5 50.0 62.5 12.5
  3 − 62.5 − − −
Lymphocyte score (%)     
 1 wk     
  1 100 37.5 62.5 50.0 42.9
  2 − 50.0 37.5 50.0 42.9
  3 − 12.5 − − 14.2
 1 mo     
  1 75.0 12.5 − 50.0 62.5
  2 25.0 62.5 75.0 50.0 37.5
  3 − 25.0 25.0 − −
Vascularization score (%)     
 1 wk     
  1 62.5 50.0 − 25.0 57.2
  2 37.5 50.0 37.5 62.5 28.6
  3 − − 62.5 12.5 14.2
 1 mo    
  1 87.5 87.5 75.0 62.5 50.0
  2 12.5 12.5 25.0 37.5 50.0
  3 − − − − −
Edema score (%)     
 1 wk     
  1 87.5 37.5 − 37.5 28.6
  2 12.5 50.0 37.5 50.0 42.9
  3 − 12.5 62.5 12.5 28.6
 1 mo     
  1 75.0 75.0 25.0 37.5 62.5
  2 25.0 25.0 50.0 50.0 37.5
  3 − − 25.0 12.5 −
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with previous results that dentin bonding agents 
cause no systemic toxicity, because resin-based 
materials release components in relatively small 
amounts.36 Therefore, systemic toxicity is of less 
value for assessing the biocompatibility of resin-
based dental materials.
OFRs may directly induce cell damage, or act as 
an intracellular messenger during cell death induced 
by various other kinds of stimuli.37 Recently, OFR 
production was described as an early expression of 
cellular stress in dental monomer cytotoxicity. Some 
components of resin-based dental materials, such 
as monomers and photoinitiators, were described as 
increasing OFR production.38−40 Furthermore, assay-
ing enzymatic and non-enzymatic antioxidants pro-
vides an indirect assessment of OFR generation in 
OS.41 When the balance between OFR production 
and antioxidative defense mechanisms is impaired, 
OFR levels may rise. When the OFRs are not removed 
by natural scavengers, damage occurs through per-
oxidation within the phospholipid structure of 
membranes.42
In conclusion, the null hypotheses were rejected. 
Histopathologic findings in this study demonstrated 
that DBSs caused local toxicity and delayed wound 
healing to different degrees when applied to con-
nective tissue of rats. However, the findings also 
showed that DBSs did not induce oxidative stress 
or an increase in serum TNF-α. Further studies are 
needed to evaluate the biocompatibility of compo-
nents of such adhesives and to determine the pos-
sible causes of these tissue reactions.
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